CA2457500A1 - Methods of determining the concentration of an analyte in a fluid test sample - Google Patents

Methods of determining the concentration of an analyte in a fluid test sample Download PDF

Info

Publication number
CA2457500A1
CA2457500A1 CA002457500A CA2457500A CA2457500A1 CA 2457500 A1 CA2457500 A1 CA 2457500A1 CA 002457500 A CA002457500 A CA 002457500A CA 2457500 A CA2457500 A CA 2457500A CA 2457500 A1 CA2457500 A1 CA 2457500A1
Authority
CA
Canada
Prior art keywords
time period
analyte
predetermined time
test sample
current
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002457500A
Other languages
French (fr)
Other versions
CA2457500C (en
Inventor
Yingping Deng
Amy H. Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Bayer Healthcare LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC
Publication of CA2457500A1 publication Critical patent/CA2457500A1/en
Application granted granted Critical
Publication of CA2457500C publication Critical patent/CA2457500C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration

Abstract

A method of determining the concentration of an analyte in a fluid test sample that in- cludes providing an electrochemical sensor adapted to measure the analyte in the test sample. The test sample sufficiently covers a counter and working electrode of the electrochemical sensor. A first potential is applied between the counter and working electrodes for a first pre- determined time period and the current is measured and the time is recorded. After the first potential is removed or substantially reduced, a second potential is applied between the counter and working electrodes and the current is measured. The concentration of the analyte is determined in the test sample as a function of the current measured. An index is calculated and compared to at least one predetermined parameter to identify when a bias, if any, exceeds a threshold. An error signal or analyte concentration is displayed depending on the compari- son.

Description

METHODS OF DETERMINING THE CONCENTRATION OF AN
ANALYTE IN A FLUID TEST SAMPLE
s FIELD OF THE INVENTION
The present invention relates to methods using biosensors and, more specifically, methods of detecting bias in determining an analyte concentration in a fluid test sample caused by incompletely filled electrochemical sensors.
io DACKGROUND OF THE INVENTION
The quantitative determination of analytes in body fluids is of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example, lactate, cholesterol and bilirubin should be monitored in certain individuals.
In particu-lar, determining glucose in body fluids is important to diabetic individuals who must fre-is quently check the glucose level in their body fluids to regulate the glucose intake in their diets. While the remainder of the disclosure herein will be directed towards determining glucose, it is to be understood that the methods of this invention may be used for deter-mining other analytes upon selection of an appropriate enzyme.
There have been various methods implemented in the past that use biosensors zo (e.g., biochemical sensors) to determine the quantity of a specific component (analyte) in a fluid sample. Some examples of these biosensors, including electrochemical sensors, are disclosed in U.S. Patent Nos. 5,120,420, 5,264,103 and 5,620,579, and U.S.
Publica-tion No. 20010042683.
Some drawbacks with existing methods that use electrochemical sensors may oc-Zs cur when an insufficient amount of the fluid sample is present. These drawbacks occur when counter and working electrodes of the electrochemical sensors are not completely covered with the fluid sample, resulting in an incomplete current flowing across the electrodes. Since the amount of analyte (e.g., glucose) detected by the electrochemical sensor is directional proportional to the current flowing through the detection meter, fail-3o ure to completely cover the electrochemical sensor's electrodes may result in a bias of the blood sample's analyte (e.g., glucose concentration).
2 It would be desirable to provide a method that detects when there is an insuffi-cient amount of fluid sample and report such a condition as an error to the user. It also would be desirable to provide a method that detects electrochemical sensors with an ab-normal rehydration process, because of an insufficient sample to completely re-hydrate the chemistry of the electrochemical sensor. It would be desirable to provide a method that determines an insufficient amount of fluid sample exists even when the electrodes of the electrochemical sensors are sufficiently covered. It would also be desirable to report such conditions as errors to the user if the bias of the analyte concentration exceeds a predetermined threshold caused by, for example, solution movement in incompletely io filled sensors or abnormal re-hydration kinetics.
SUMMARY OF THE INVENTION
According to one method of determining the concentration of an analyte in a fluid test sample, an electrochemical sensor adapted to measure the analyte in the fluid test is sample is provided. The electrochemical sensor has a counter electrode and a working electrode. The counter and working electrodes of the electrochemical sensor are suffi-ciently covered by the fluid test sample. A first potential is applied between the counter electrode and working electrode for a first predetermined time period. The current is measured between the counter electrode and working electrode at a plurality of times ao during the first predetermined time period. The times of the measurements during the first predetermined time period is recorded. The first potential is removed or substan-tially reduced between the counter electrode and working electrode for a second prede-termined time period. A second potential is applied between the counter electrode and working electrode for a third predetermined time period. The current is measured be-ar tween the counter electrode and working electrode at least once during the third prede-termined time period.
The concentration of the analyte in the fluid test sample is determined as a func-tion of the current measured. An index is calculated using at least two of the following:
a measured current and recorded time of the first predetermined time period, and the so measured current of the third predetermined time period. The index is compared to at least one predetermined parameter related to the determined concentration of analyte in
3 the fluid test sample to identify when a bias, if any, exceeds a predetermined threshold.
An error signal or an analyte concentration is displayed depending on the comparison between the index and the at least one of the predetermined parameter.
According to another method of determining the concentration of an analyte in a s fluid test sample, an electrochemical sensor adapted to measure the analyte in the fluid test sample is provided. The electrochemical sensor has a counter electrode and a work-ing electrode. The counter and working electrodes of the electrochemical sensor are suf ficiently covered by the fluid test sample. A first potential is applied between the counter electrode and working electrode for a first predetermined time period. The current is io measured between the counter electrode and working electrode a plurality of times during the first predetermined time period. The times of the measurements during the first pre-determined time period is recorded. The first potential is removed or substantially re-duced between the counter electrode and working electrode for a second predetermined time period. A second potential is applied between the counter electrode and working is electrode for a third predetermined time period. The current is measured between the counter electrode and working electrode at least once during the third predetermined time period.
The concentration of the analyte in the fluid test sample is determined as a func-tion of the current measured. An index (I) is calculated by solving the equation:
ao I = (In/Ib",~)* Tb", where In = the last measurement of the current during the third predeter-mined time period, Ibm~ = the highest current measured during the first predetermined Zs time period, and Tbm~= the time of the highest measured current is measured during the first predetermined time period.
The index is compared to at least one predetermined parameter related to the determined concentration of analyte in the fluid test sample to identify when a bias, if any, exceeds a 3o predetermined threshold. An error signal or an analyte concentration is displayed de
4 pending on the comparison between the index and the at least one of the predetermined parameter.
According to a further method of determining the concentration of an analyte in a s fluid test sample, an electrochemical sensor adapted to measure the analyte in the fluid test sample is provided. The electrochemical sensor has a counter electrode and a work-ing electrode. The counter and working electrodes of the electrochemical sensor are suf ficiently covered by the fluid test sample. A first potential is applied between the counter electrode and working electrode for a first predetermined time period. The current is ~ o measured between the counter electrode and working electrode at a plurality of times during the first predetermined time period. The times of the measurements during the first predetermined time period is recorded. The first potential is removed or substan-tially reduced between the counter electrode and working electrode for a second prede-termined time period. A second potential is applied between the counter electrode and is working electrode for a third predetermined time period. The current is measured be-tween the counter electrode and working electrode at least once during the third prede-termined time period.
The concentration of the analyte in the fluid test sample is determined as a func tion of the current measured. An index is calculated using a measured current and re zo corded time of the first predetermined time period, and the measured current of the third predetermined time period. The index is compared to at least one predetermined pa-rameter related to the determined concentration of analyte in the fluid test sample to identify when a bias, if any, exceeds a predetermined threshold. An error signal or an analyte concentration is displayed depending on the comparison between the index and zs the at least one of the predetermined parameter.
According to yet another method of determining the concentration of an analyte in a fluid test sample, an electrochemical sensor adapted to measure the analyte in the fluid test sample is provided. The electrochemical sensor has a counter electrode and a working electrode. The counter and working electrodes of the electrochemical sensor are so sufficiently covered by the fluid test sample. A potential is applied between the counter electrode and working electrode for a predetermined time period. The current is meas-ured between the counter electrode and working electrode at a plurality of times during the predetermined time period. The times of the measurements during the predetermined time period is recorded. The concentration of the analyte in the fluid test sample is de-termined as a function of the current measured. An index is calculated using a selected s measured current and recorded time of the predetermined time period. The index is compared to at least one predetermined parameter related to the determined concentration of analyte in the fluid test sample to identify when a bias, if any, exceeds a predetermined threshold. An error signal or an analyze concentration is displayed depending on the comparison between the index and the at least one of the predetermined parameter.
to BRIEF DESCRIPTION OF THE DRAWINGS
FIG. I is an exploded view of an electrochemical sensor according to one em-bodiment that may be used in a method of the present invention;
FIG. 2 is a sensor base and those elements that are applied directly to the base of the sensor in FIG. 1;
~s FIG. 3 is flowchart depicting a sequence of steps to determine the concentration of an analyte in a fluid test sample according to one method of the present invention; and FIG. 4 is a flowchart depicting a sequence of steps to determine an index and re-port an under-fill condition to the user according to one method of the present invention.
While the invention is susceptible to various modifi-zo cations and alternative forms, specific embodiments thereof has been shown by way of example ~.n the drawing and will herein be described in detail. Ii. should be understood, however, that it is not intended to limit the invention to the particular forms disclosed but, on the contrary, the is intention is to cover all modifications, equivalents, and alternative s falling within the spirit and scope of the in-vention as defined by the appended claims.
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENT
3o The present invention relates to methods using biosensors and, more specifically, methods of detecting bias in determining the concentration of an analyte caused by in-completely filled biosensors (i. e., an under-fill condition). By detecting high-biased analyze results caused by, for example, sample movement inside an incompletely filled biosensor, the biosensor's performance can be improved. Other abnormal conditions may include an insufficient sample to completely dissolve the sensor's chemistry. The s biosensor's performance is improved by reporting such results as an under-filled error to the user. It is desirable to be able to detect and report an under-filled error that occurs when one of the electrodes of an under-filled sensor is not contacted with the fluid test sample: An example of such a condition is when the fluid test sample is sufficient to make contact between the working the counter electrodes, but insufficient to completely io fill the capillary (e.g., about 3.5 ~,L). The bias may occur when blood moves up the cap-illary when the sensor is pulled away from the whole blood samples due to the breaking of the meniscus and capillary action. The magnitude of the bias on the final glucose reading depends on the percentage of blood volume in the sensor capillary and the time when the sensor is pulled away from the sample drop.
is As discussed above, the analyze to be tested may be glucose in a whole blood sample. The analyte (e.g., glucose) concentration of the fluid test sample (e.g., whole blood sample) may be determined using an amperometric monitoring system.
Electrochemical Sensor zo To determine the glucose concentration in a whole blood sample, an electro-chemical sensor according to one embodiment is provided. It is important that the elec-trochemical sensor provides reliable and reproducible measurements. According to one embodiment, the electrochemical sensor in the present invention may be that described in U.S. Patent Application published as 20010042683 on November 22, 2001 and entitled zs Electrochemical-Sensor Design, which is incorporated by reference in its entirety.
An example of an electrochemical sensor described in U.S. Patent Application published as 20010042683 is depicted in FIG. 1. Referring to FIG. 1, a sensor 34 com-prises an insulating base 36 upon which is printed in sequence (typically by screen print-ing techniques), an electrical conductor pattern 38, an electrode pattern (portions 39 and so 40), an insulating (dielectric) pattern 42, and a reaction layer 44. The base of the elec-trochemical sensor provides a flow path for the fluid test sample. The sensor base is shown in FIG. 2 in which all of the elements on the base are shown in the same plane.
The function of the reaction layer 44 is to convert glucose, or another analyte in the fluid test sample, stoichiometrically into a chemical species which is electrochemi s cally measurable, in terms of electrical current it produces, by the components of the electrode pattern. The reaction layer 44 generally contains a biosensing or reagent mate-rial, such as an enzyme, and an electron acceptor. More specifically, the reaction layer 44 contains an enzyme that reacts with the analyte to produce mobile electrons on the electrode pattern and an electron acceptor (e.g., a ferricyanide salt) to carry the mobile io electrons to the surface of the working electrode. The electron acceptor may be referred to as a mediator in which the mediator is reduced in response to a reaction between the analyte and the enzyme. The enzyme in the reaction layer may be combined with a hy drophilic polymer, such as polyethylene oxide. An enzyme that may be used to react with glucose is glucose oxidase. It is contemplated that other enzymes may be used such o s as glucose dehydrogenase.
The two portions 39, 40 of the electrode pattern provide the respective working ,, and counter electrodes necessary to electrochemically determine the analyte.
The work-ing electrode typically corriprises an enzyme that reacts with the analyte.
The working and counter electrodes may be configured such that the major portion of the counter ao electrode is located downstream (in terms of the direction of fluid flow along the flow path) from the exposed portion of the working electrode 39a. This configuration allows the test fluid sample to completely cover the exposed portion of the working electrode for all cases in which an undetected partial fill has occurred.
Counter electrode sub-element 40a, however, is positioned up-stream from is working electrode upper element 39a so that when an inadequate amount of the test fluid sample (e.g., a whole blood sample) to completely cover the working electrode enters the capillary space, an electrical connection forms between counter electrode sub-element 40a and exposed portion of the working electrode 39a due to the conductivity of the whole blood sample. The area of the counter electrode, however, that is available for 30 contact by the whole blood sample is so small that only a very weak current can pass between the electrodes and, thus, through the current detector. By programming the cur-rent detector to give an error signal when the received signal is below a certain pre-determined level, the sensor device informs the user that insufficient blood has entered the sensor's cavity and that another test should be conducted. While the particular di-mensions of the electrodes are not critical, the area of the counter electrode sub-element s 40a is typically less than about 10% than that of the working electrode and, more specifi-cally, less than about 6%. This element should be made as small as possible in view of the restraints of the screen printing process.
It is also contemplated that the reaction layer 44 may be removed from contact with counter electrode sub-element 40a. This is accomplished by producing a screen that io does not print reagent ink over the counter electrode sub-element 40b: This serves the purpose of starving the sub-element for reagent, thereby not allowing it to function as a proper counter electrode, so that an error condition is achieved when the test fluid sample fails to contact the bulk of the counter electrode 40. While sub-element 40a is depicted as being physically connected to, and therefore part of, the counter electrode 40, such is physical connection is not critical. Such sub-element may be physically disconnected from the rest of the counter electrode provided that it has its own connector and the sen-sor is equipped with a third contact to the detector.
The working and counter electrodes include electrode ink. The electrode ink, which is generally about 14p, (0.00055") thick, typically contains electrochemically ac ao five carbon. Components of the conductor ink may be a mixture of carbon and silver that is chosen to provide a low chemical resistance path between the electrodes and the meter with which they are in operative connection via contact with the conductive pattern at a fish-tail end 45 of the sensor. The counter electrode may be comprised of silver/silver chloride although carbon is preferred. To enhance the reproducibility of the meter read-Zs ing, the dielectric pattern insulates the electrodes from the fluid test sample except in a defined area near the center of the electrode pattern 43. A defined area is important in this type of electrochemical determination because the measured current depends on the analyte concentration and the area of the reaction layer that is exposed to the analyte-containing test sample.
so A typical dielectric layer 42 comprises a I1V-cured acrylate modified polyurethane that is about 10~t (0.0004") thick. A lid or cover 46 is adapted to mate with the base to form a space to receive the fluid test sample in which the counter and working electrodes axe situated. The lid 46 provides a concave space 48, and is typically formed by embossing a flat sheet of deformable material. The lid 48 is punctured to provide an air vent 50 and joined to the base 36 in a sealing operation. The lid and base can be s sealed together by sonic welding in which the base 36 and lid 46 are first aligned and then pressed together between a vibratory heat sealing member or horn and a stationary jaw. The horn is shaped such that contact is made only with the flat, non-embossed re-gions of the lid. Ultrasonic energy from a crystal or other transducer is used to excite vi-brations in the metal horn. This mechanical energy is dissipated as heat in the polymeric io joint allowing the bonding of the thermoplastic materials. The embossed lid and base may be joined by using an adhesive material on the underside of the lid. The method of joining the lid and base are more fully described in U.S. Pat. No. 5,798,031 which is in-corporated herein by reference in its entirety..
Suitable materials for the insulating base 36 include polycarbonate;
polyethylene is terephthalate, dimensionally-stable vinyl and acrylic polymers, and polymer blends such as polycarbonate/polyethylene terephthalate and metal foil structures (e.g., a ny-lon/aluminumlpolyvinyl chloride laminate). The lid is typically fabricated from a de-formable polymeric sheet material such as polycarbonate, or an embossable grade of polyethylene terephthalate, glycol modified polyethylene terephthalate or a metal foil Zo composition (e.g., an aluminum foil structure). The dielectric layer may be fabricated from an acrylate-modified polyurethane that is curable by U~l light or moisture or a vinyl polymer that is heat curable.
It is contemplated that other electrochemical sensors may be used in the present invention. Examples of an electrochemical sensor that can be used to measure glucose Zs concentrations are those used in Bayer Corporation's Glucometer DEX~ and ELITE~
systems. More details on such an electrochemical sensor may be found in U.S.
Patent Nos. 5,120,420 and 5,320,232 which are both incorporated by reference in their entirety.
One or more of the electrochemical sensors may be purchased from Matsushita Electric Industrial Company. Another electrochemical sensor is disclosed in U.S. Patent No.
30 5,798;031, which is incorporated by reference in its entirety. A further example of an electrochemical sensor that may be used in an amperometric monitoring system is dis-l closed in U.S. Patent No 5,429,735. It is contemplated that other biosensors may be used in the present invention.
The electrochemical sensors may be located in a blood glucose sensor dispensing instrument that is adapted to have loaded therein a sensor pack that includes a plurality of sensors or testing elements. Each of the sensors is adapted to be ejected from the sensor pack. One example of a sensor pack loaded in a sensor dispensing instrument is dis-closed in U.S. Patent No. 5,660,791. It is contemplated that the electrochemical sensors may be stored in other apparatus such as bottles.
i o Methods of the Present Invention A method of determining the concentration of an analyte in a fluid test sample of the present invention may include using one of the electrochemical sensors described above (e.g., sensor 34). The electrochemical sensor includes a counter electrode and a working electrode. It is contemplated that other electrochemical sensors may be used ~ s than described in connection with FIGS. l and 2.
Referring to FIG. 3, step 110 applies a first potential between the counter -elec-trode and working electrode. The fluid test sample with analyte is added so as to contact the electrochemical sensor in step 120. The first potential is applied between the counter and working electrodes for a first predetermined time period. The first potential is gener-zo ally from about 100 to about 600 mV and, more typically, from about 300 to about 500 mV.
The current is measured between the counter electrode and working electrode at a plurality of intervals, and the times of the measurements are recorded during the first predetermined time period during step 130. The first predetermined time period is gen-zs erally from about 2 to about 30 seconds and, more typically, from about 5 to about 15 seconds. The current during the first predetermined time period may be measured in regular intervals that may vary in duration. For example, the current during the first pre-determined time period is generally measured in regular intervals of from about 0.1 to about 3 seconds, and, more typically, from about 0.2 to about 0.6 seconds.
During the 3o measuring of the current, the time of such measurements is recorded. The first predeter-mined time period is referred to as the "burn-off' period.

During step 140, the first potential between the counter electrode and working electrode is removed or substantially reduced for a second predetermined time period.
The second predetermined time period is generally from about 2 to about 20 seconds and, more typically, from about 5 to about 15 seconds. The second predetermined time period s is referred to as the "wait" or "incubation" period.
A second potential between the counter electrode and working electrode is ap-plied for a third predetermined time period in step 150. The second potential is generally from about 100 to about 600 mV and, more typically, from about 300 to about 500 mV.
The current is measured between the counter and working electrodes during the third ro predetermined time period in step 160. The third predetermined time period is generally from about 2 to about 30 seconds and, more typically, from about 5 to about 1f seconds.
The current during the third predetermined time period may be measured in regular inter-vals that may vary in duration. For example, the current is generally measured in regular intervals of from about 0.1 to about 3 seconds, and, more typically, from about 0.2 to is about 0.5 seconds. The third predetermined time period is referred to as "read" period.
According to another method, the second and third predetermined time periods may be eliminated.
According to one method, the concentration of the analyte is determined in the fluid test sample as a function of the current measured during the third predetermined Zo time period in step 170. It is contemplated, however, that the concentration of the ana-lyte may be determined as a function of the current measured during the first predeter-mined time period.
To assist in determining if an under-fill condition is present when the electrodes of the electrochemical sensor are not sufficiently covered by the test fluid sample; the is analyte concentration may be compared to at least one factor, such as the k-factor and/or read-to-burn ratio. The electrochemical sensor is configured so that in the event of an under-fill condition, the result will be affirmative as opposed to a neutral response, i. e. a failure of the detector to give any signal. Thus, for example, when the amount of the test fluid sample that enters the capillary space is sufficient to cover the counter electrode so sub-element 40a or 40b and that portion of the working electrode 39a which lies up-stream from the main portion of the counter electrode 40, the detector will sense a current but the current will be weaker than if the working and counter electrodes were com-pletely or sufficiently covered with the test fluid sample. The detector may be connected with the reading means to display an error signal to the user when an under-fill condition occurs.
s There are provided means for sensing certain characteristics of the current over time that are used along with the absolute current level to determine if an error condition has occurred. This is accomplished by algorithmically programming the meter to detect the under-fill condition by measuring the current at a definite time period after the test fluid has electrically connected the sub-element of the counter electrode with the working io . electrode. The ratio of the currents for the two measurements is used to determine if the sensor has filled properly. For example, the current is measured at 5 and 10 seconds after applying the driving potential to the circuit, and these two currents are converted into a ratio. This ratio and the current reading at 10 seconds are used to determine if the sen-sor's capillary space has filled properly.
is A sample calculation is as follows: three current measurements are made during the test sequence according to one method: (a) at the end of an initial period known as the "burn-off' period in which the driving potential has been applied for a first predeter-mined time period (e.g., 10 seconds denoted as Iblo); (b) when the potential is applied and measured during the third predetermined time interval or "read" period at, for example, 5 zo seconds (hs), and (c) at the end of the third predetermined time period (e:g., 10 seconds) known as the "read" period denoted as hlo. It is contemplated that the time periods may vary from the exemplary times above. Two parameters may be determined from these three current measurements. At least one of these two parameters is used to determine if the sensor's capillary space has filled properly. The first parameter is the decay factor, k, zs which describes the shape of current time course. The second parameter is a ratio that characterizes the rate of decay in the current level during the read phase.
The decay factor, k, is defined as:
k = ln(ITs) - ln(Irio) ~ (ln(10) - ln(S)) 3o Equation A
The Read-to-Burn ratio, RlB, is defined as:

~ = Irio ~~io Equation B
One example of criteria for an under-fill condition using these two parameters may be as s follows:
( 1 ) If k <0.227 or k>0.497; or (2) If RB <0.263 or RIB >1.263.
io It is contemplated that the numbers of this criteria may vary fox the decay factor, k, and the Read-to-Burn ratio, RIB, in determining whether an under-fill condition is present.
An under-filled sensor produced the following three current measurements:
An example using these parameters with an under-filled condition is as follows:
Ibio=505.1 nA, hs=656.5 nA, and Ic,o=561.8nA..
is The decay factor and Read-to-Burn ratio were calculated from these current measure-ments:
Decay factor _ ln(Irs ) - ln(Ir,o ) ln(656.5) - ln(561.8) k ln(10) - ln(5) ln(10) - ln(5) ~ 0.22 Read-to-Burn ratio R/B = Irio / Iblo = 561.8/505.1 = 1.11 These two parameters were used to detect the following error conditions:
2s ~ k<0.227 or k>0.497 at this glucose readback level. True; because k=0.22 <0.227;
~ RIB<0.263 or R/B>1.263 at this glucose readback level. False, because R/B =
1.11 >0.263 and <1.263.
By providing a device which gives a positive (as opposed to a neutral) response in 3o the event of an under-fill condition when the electrodes of the electrochemical sensor are not sufficiently covered by the test fluid sample, the user will recognize that the abortive function of the test is a result of too little blood entering the capillary space, rather than some other malfunction having caused the anomalous result. Such a comparison works well when the counter electrode of an under-filled sensor is not contacted with the blood sample. The counter electrode (without movement of the whole blood sample) is not typically contacted with the blood sample in DEX system when the whole blood sample is below about 2.S~L or 2.OpL.
To improve the detection of certain under-fill conditions (e.g., a condition where s the whole blood sample is moving such that the sensor capillary is incompletely filled but the whole blood sample is in contact with the counter electrode), an index is calculated in the present invention. An index is calculated in step 190 according to one process by using at least two of the following: one measured current and recorded time duxing the first predetermined time period, and at least one measured current of the third time pe-~o riod.
One example of an index that may be used in the present invention is by solving Equation C which uses all three variables:
Equation C: Index (I) _ (I~/Ib",~)* Tbm where:
is Irt= a current measured during the first or third predetermined time period (e.g., the last measurement of the current during the third predetermined time period), Ibm~ = the highest current measured during the first predetermined time period, and Tbm~ = the time when the highest current is measured during the first Zo predetermined time period.
It is contemplated that other equations may be used to determine an index in the present invention that may use less than the above three variables. For example, two of these variables (a measured current and recorded time of the first determined time period and the measured current of the third predetermined .time period) may be used to deter-Zs mine an appropriate index. One example of such is to determine an appropriate index by using the slope of the measured current and recorded time of the first determined time period. Alternatively, it is contemplated that other indices may be created using the slope of (a) the measured current of the first predetermined time period and the measured cur-rent of the third predetermined time period, or (b) the recorded time of the first predeter-3o mined time period and the measured current of the third predetermined time period.

In step 200, the index is compared to at least one predetermined parameter related to the determined concentration of analyte in the fluid test sample to identify when the bias exceeds a predetermined threshold, which is obtained from step 180. The predeter-mined parameters) is typically stored in the meter.
s Depending on whether the index is within at least one of the predetermined pa-rameter; either an error signal is displayed (step 210) or the analyte concentration is dis-played (step 220). According to one process, an error signal is displayed when the index is not within the at least one predetermined parameter and the analyte concentration is displayed when the index is within the at least one predetermined parameter.
Alterna-~o tively, the error signal may be displayed when the index is within the at least one prede-termined parameter and the analyte concentration is displayed when the index is not within the at least one predetermined parameter.
An example of determining an index and comparing it with a predetermined pa-rameter is shown in FIG. 4. The index is calculated as described above in Equation C in is step 330 using the In= the last measurement of the current during the third predetermined time period from step 300, Ibm~ = the highest current measured during the first predeter-mined time period from step 310, and Tbm~ = the time when the highest current is meas-ured during the first predetermined time period from step 320.
The index from step 330 is compared in step 350 to a predetermined parameter zo taken from step 340. In this example, the predetermined parameter is 1.5.
It is contem-plated that the predetermined parameter may be different than shown in step 340. 'The predetermined parameter is related to the level of glucose concentration. If the index is greater than the predetermined parameter of 1.5, then a display error is indicated at step 360. If the index is less than or equal to 1.5, then the analyte concentration will be cal-zs culated and reported to the user in step 370.
The method for determining the analyte concentrations (e:g., glucose concentra-tions) may be performed in disposable self testing systems. The disposable self testing systems are often used by end consumers, especially those who are diabetic.
Alterna-tively, the method for determining the analyte concentrations (e.g.,. glucose concentra-so tions) may be performed in clinical analyzers. Clinical analyzers are often used in hos-pitals or clinics.

The testing end of the sensor is adapted to be placed into contact with the fluid sample (e.g., a whole blood sample) to be tested. The whole blood sample may be gener-ated by a lancing device such as a microlet. The lancing device may obtain blood by, e.g., pricking a person's finger. According to one process, the whole blood sample may s be prepared for testing by (a) removing the electrochemical sensor from a packet, (b) placing the electrochemical sensor into a glucose concentration measuring instrument, (c) generating a whole blood sample, and (d) bringing the sensor and the whole blood sam-ple into contact wherein the blood is generally drawn into the sensor by capillary action:
According to one process, a whole blood sample is introduced into the space via ~o an introducing port. Gas is discharged from the space by the inflow of the whole blood sample via a discharge port. It is believed that the glucose in the whole blood sample reacts with the enzyme (e.g, glucose oxidase earned on the electfodes to produce glu-conic acid). A voltage is applied {e.g., 600 mV) between the electrodes and the electrode for measurement is polarized in the anode direction. By applying a voltage in the anode z s direction, an oxidizing current for the produced hydrogen peroxide is obtained. This cur-rent level corresponds to the concentration of glucose in the whole blood sample.
Examples Several experiments were performed to show the effects of the glucose concen-zo trations of a whole blood sample using a under-filled test sensors (see Table 1 ). Also, several experiments were performed using a whole blood sample in a proper filled con-dition (see Table 2).
Table 1 Testing Procedure Whole blood samples of 3~L were tested 15 times with various solution move-zs ment during the testing. In other words, some samples moved slightly, while others were moved to a greater extent. The whole blood samples were taken from the same source and, thus, had about the same glucose concentration.
The testing was performed using the following steps. First, a positive potential of 400 mV was applied between the working electrode and the counter electrode of the 3o electrochemical sensor. The electrochemical sensor that was used. was taken from Bayer Corporation's Glucometer DEX~ system. A 3~L whole blood sample was added to and contacted the electrochemical sensor. The current was measured between the working and the counter electrodes every 0.3 second for 10 seconds during the "burn"
period.
This current is referred to as the burn current. The respective times were also recorded that corresponded to the measurements of the burn current. The potential between the s working and counter electrodes was removed, resulting in an open circuit fox a time pe-riod of 10 seconds. This time period is referred to as the "wait" or "incubation" period.
A positive potential of 400 mV was re-applied between the working and the counter electrodes of the electrochemical sensor. The current was measured between the working electrode and the counter electrode every 0.3 second for 10 seconds during the "read"
io period. This current is referred to as the read current. The read current was used to de-termine the glucose concentration of the whole blood sample.
This glucose calculation was then compared to predetermined parameters of k-factor and the read-to-burn ratio to determine if the blood sample amount was not suffi-cient. These ratios were calculated in the same manner as described above in the appli-~ s cation in Equations A and B.
The index was calculated as described above in Equation C and then compared to a predetermined index of 1.5. If the index was greater than 1.5, then an error was dis-played. If the index was less than or equal to 1.5, then the analyte concentration was re-ported. The test results are shown in Table 1 below.
Zo The % bias from 10~L, which is an example of 100% filled condition, was cal-culated as follows in Equation D:
Equation D: (Glucose~,y °"a~~n volume - GIuCOSe~p~L~IG111COSelOuL
* 1.00 The lOuL sample was used to ensure that the sensors were 100% filled.

Table i ReplicateTb~r Ie",~r I~~o Index % Bias Error out No. sec (nA nA _ __ ., es/na 1 0.3 4230 1407 0.10 1.74 No 2 0.3 6561 1321 0.06 -4.48 No 3 5.7 71 1472 1.45 6.44 No 4 7.8 _ 1552 2.95 12.22 Yes _ _ 140 0.78 1.66 No 2.1 38 6 6 0.9 _ _ 0.25 1.95 No 7 1.8 14115 1441 0.18 4.95 No 8 1.5 11557 1444 0.19 No
5.I7 9 8.4 4452 1579 _ _ _ Yes 2.98 15.00 2.7 8631 1477 0.46 7:57 No 11 L5 11364 1434 0.19 4.44 No 12 0.9 5210 1360. 0.23 -0.95 No 13 2.4 9261 1451 0.38 5.68 No 14 1.8 11665 1403 0.22 2.18 No 5.7 5627 1511 1.53 10.05 Yes As can be seen in Table 1 above, Replicate Nos. 4, 9 and 15 had indices greater 5 than 1.5 and, thus, produced an error signal to the user. ~n the other hand, Replicate Nos. 1-3, 5-8 and 10-14 did not have indices greater than 1.5 and, thus, did not display an error signal to the user. This test indicates that when a sensor is incompletely filled (such as with a 3~IL whole blood sample), then high biased results may occur that are unac-ceptable. This was confirmed when Replicate Nos. 4, 9 and 15, independent of the index to and the resulting error signal, had % biases greater than 10%. In these examples, the de-cay factor, k, and the Read-to-Burn ratio, RIB, would be within their normal boundaries in determining whether an under-fill condition is present because the counter and work-ing electrodes would be sufficiently covered with a 3~.L whole blood sample.
In other words, using k and/or R/B would not have detected the high biased results.
is Table 2 Testing; Procedure Whole blood samples of 10~.L were tested 15 times without any solution move-ment during sampling. The whole blood samples were taken from the same source and, thus, had about the same glucose concentration. The testing procedure was the same as 2o set forth above in the testing procedure of Table 1.

Table 2 ReplicateTbma~ lbmar . lno Index % Bias Error out No. (sec eslno) I 2.1 4133 1401 0.71 1.30 No ~~

2 2.7 3402 1398 1.11 1.08 No 3 1.2 3878 1291 0.40 -6.65 No 4 2.1 4017 1441 0:75 4.19 No 1.8 4041 1409 0.63 1.88 No
6 2.4 3686 1360 0.89 -1.66 No
7 1.5 4313 1423 0.49 3.64 No
8 1.5 4860 1318 0.41 -4.01 No
9 1.2 4915 1392 0.34 1.38 No 1.5 4546 1389 0.46 1.17 No I1 1.8 4285 1390 0.58 1.24 No 12 1.5 4638 1324 0.43 -3.57 No s As can be seen in Table 2 above, none of the Replicate Nos. 1 ~ 15 had indices greater than 1.5 and, thus, none produced an error signal to the user. This showed that a completely filed whole blood sample without solution movement did not produce an er-ror signal to the user using the calculated index and the predetermined parameter of 1.5.
While particular embodiments and applications of the present invention have to been illustrated and described, it is to be understood that the invention is not limited to the precise construction and compositions disclosed herein and that various modifica-tions, changes, and variations may be apparent from the foregoing descriptions without departing from the spirit and scope of the invention as defined in the appended claims.

Claims (36)

WHAT IS CLAIMED IS:
1. A method of determining the concentration of an analyte in a fluid test sample comprising:
providing an electrochemical sensor adapted to measure the analyte in the fluid test sample, the electrochemical sensor having a counter electrode and a working elec-trode;
sufficiently covering the counter and working electrodes of the electrochemical sensor with the fluid test sample;
applying a first potential between the counter electrode and working electrode for a first predetermined time period;
measuring the current between the counter electrode and working electrode at a plurality of intervals during the first predetermined time period;
recording the times of the at least one measurement during the first predetermined time period;
removing or substantially reducing the first potential between the counter elec-trode and working electrode for a second predetermined time period;
applying a second potential between the counter electrode and working electrode for a third predetermined time period;
measuring the current between the counter electrode and working electrode at least once during the third predetermined time period;
determining the concentration of the analyte in the fluid test sample as a function of the current measured;
calculating an index using at least two of the following: a measured current and recorded time of the first predetermined time period, and the measured current of the third predetermined time period;
comparing the index to at least one predetermined parameter related to the deter-mined concentration of analyte in the fluid test sample to identify when a bias, if any, ex-ceeds a predetermined threshold; and displaying either an error signal or an analyte concentration depending on the comparison between the index and the at least one of the predetermined parameter.
2. The method of claim 1, wherein the analyte is glucose and the fluid test sample is a whole blood sample.
3. The method of claim 2, wherein the glucose concentration of the whole blood sample is determined using an amperometric monitoring system.
4. The method of claim 1, wherein the electrochemical sensor includes a base that provides a flow path for the fluid test sample and has on its surface the counter electrode and working electrode in electrical communication with an electrical current detector, a reaction layer an the surface of at least the working electrode comprising an enzyme that reacts with the analyte in the fluid test sample, and a lid adapted to mate with the base to form a space to receive the fluid test sample in which the counter and working electrodes are situated.
5. The method of claim 4, wherein the enzyme of the reaction layer is com-biped with a hydrophilic polymer.
6. The method of claim 4, wherein the enzyme is glucose oxidase.
7. The method of claim 1, wherein the electrochemical sensor includes an enzyme and a mediator in the enzyme, the mediator is a ferricyanide salt and is reduced in response to a reaction between the analyte and the enzyme.
8. The method of claim 1, wherein the first predetermined time period is from about 2 to about 30 seconds.
9. The method of claim 8, wherein the first predetermined time period is from about 5 to about 15 seconds.
10. The method of claim 8, wherein the current is measured in regular inter-vats of from about 0.1 to about 3 seconds during the first predetermined time periods, and recording the time of such measurements.
11. The method of claim 10, wherein the current is measured in regular inter-vats of from about 0.2 and about 0.5 seconds, and recording the time of such measure-menu.
12. The method of claim 1, wherein the second predetermined time period is from about 2 to about 20 seconds.
13. The method of claim 12, wherein the second predetermined time period is from about 5 to about 15 seconds.
14. The method of claim l, wherein the third predetermined time period is from about 2 to about 30 seconds.
15. The method of claim 14, wherein the third predetermined time period is from about 5 to about 15 seconds.
16. The method of claim l, wherein the index (I) is calculated by solving the equation:

I = (I rt/I bmax)* T bmax where I rt = the last measurement of the current during the third predetermined time pe-riod, T bmax = the highest current measured during the first predetermined time period, and T bmax = the time of the highest measured current is measured during the first pre-determined time period.
17. The method of claim 1, further including comparing the determined ana-lyte concentration to at least one of the k-factor and read-to-burn ratio to assist in deter-mining if an underfill condition is present.
18. The method of claim 1, wherein the error signal is displayed when the in-dex is not within the at least one predetermined parameter.
19. The method of claim 1, wherein the concentration of the analyte is deter-mined in the fluid test sample as a function of the current measured during the third pre-determined time period.
20. The method of claim 1, wherein the method of determining the concen-tration of the analyte in the fluid test sample occurs in a disposable self-testing system.
21. The method of claim 1, wherein the method of determining the concen-tration of the analyte in the fluid test sample occurs in a clinical analyzer.
22. The method of claim 1, wherein the index is calculated using the meas-ured current and recorded time of the first predetermined time period, and the measured current of the third predetermined time period;
23. A method of determining the concentration of an analyte in a fluid test sample comprising:
providing an electrochemical sensor adapted to measure the analyte in the fluid test sample, the electrochemical sensor having a counter electrode and a working elec-trode;
sufficiently covering the counter and working electrodes of the electrochemical sensor with the fluid test sample;
applying a first potential between the counter electrode and working electrode for a first predetermined time period;

measuring the current between the counter electrode and working electrode at a plurality of times once during the first predetermined time period;
recording the times of the at least one measurement during the first predetermined time period;
removing or substantially reducing the first potential between the counter elec-trode and working electrode for a second predetermined time period;
applying a second potential between the counter electrode and working electrode for a third predetermined time period;
measuring the current between the counter electrode and working electrode at least once during the third predetermined time period;
determining the concentration of the analyte in the fluid test sample as a function of the current measured;
calculating an index (I) by solving the equation:
I = (I rt/I bmax)* T bmax where I rt = a selected measurement of the current during the third prede-termined time period, I bmax = the highest current measured during the first predetermined time period, and T bmax = the time of the highest measured current is measured during the first predetermined time period;
comparing the index to at least one predetermined parameter related to the deter-mined concentration of analyte in the fluid test sample to identify when a bias, if any, ex-ceeds a predetermined threshold; and displaying either an error signal or an analyte concentration depending on the comparison between the index and the at least one of the predetermined parameter.
24. The method of claim 23, wherein the analyte is glucose and the fluid test sample is a whole blood sample.
25. The method of claim 23, further including comparing the determined analyte concentration to at least one of the k-factor and read-to-burn ratio to assist in de-termining if an underfill condition is present.
26. The method of claim 23, wherein I rt is the last measurement of the current during the third predetermined time period.
27. A method of determining the concentration of an analyte in a fluid test sample comprising:
providing an electrochemical sensor adapted to measure the analyte in the fluid test sample, the electrochemical sensor having a counter electrode and a working elec-trode;
sufficiently covering the counter and working electrodes of the electrochemical sensor with the fluid test sample;
applying a first potential between the counter electrode and working electrode for a first predetermined time period;
measuring the current between the counter electrode and working electrode at a plurality of times during the first predetermined time period;
recording the times of the at least one measurement during the first predetermined time period;
removing or substantially reducing the first potential between the counter elec-trode and working electrode for a second predetermined time period;
applying a second potential between the counter electrode and working electrode for a third predetermined time period;
measuring the current between the counter electrode and working electrode at least once during the third predetermined time period;
determining the concentration of the analyte in the fluid test sample as a function of the current measured;
calculating an index using a measured current and recorded time of the first pre-determined time period, and the measured current of the third predetermined time period;

comparing the index to at least one predetermined parameter related to the deter-mined concentration of analyte in the fluid test sample to identify when a bias, if any, ex-ceeds a predetermined threshold; and displaying either an error signal or an analyte concentration depending on the comparison between the index and the at least one of the predetermined parameter.
28. The method of claim 27, wherein the analyte is glucose and the fluid test sample is a whole blood sample.
29. The method of claim 27, further including comparing the determined analyte concentration to at least one of the k-factor and read-to-burn ratio to assist in de-termining if an underfill condition is present.
30. A method of determining the concentration of an analyte in a fluid test sample comprising:
providing an electrochemical sensor adapted to measure the analyte in the fluid test sample, the electrochemical sensor having a counter electrode and a working elec-trode;
sufficiently covering the counter and working electrodes of the electrochemical sensor with the fluid test sample;
applying a potential between the counter electrode and working electrode for a predetermined time period;
measuring the current between the counter electrode and working electrode at a plurality of intervals during the predetermined time period;
recording the time of the plurality of measurements during the predetermined time period;
determining the concentration of the analyte in the fluid test sample as a function of the current measured;
calculating an index using at least one selected measured current and recorded time of the predetermined time period;

comparing the index to at least one predetermined parameter related to the deter-mined analyte concentration in the fluid test sample to identify when a bias, if any, ex-ceeds a predetermined threshold; and displaying either an error signal or an analyte concentration depending on the comparison between the index and the at least one of the predetermined parameter.
31. The method of claim 30, wherein the analyte is glucose and the fluid test sample is a whole blood sample.
32. The method of claim 31, wherein the glucose concentration of the whole blood sample is determined using an amperometric monitoring system.
33: The method of claim 30, wherein the first predetermined time period is from about 2 to about 30 seconds.
34. The method of claim 30, further including comparing the determined analyte concentration to at least one of the k-factor and read-to-burn ratio to assist in de-termining if an underfill condition is present.
35. The method of claim 30, wherein the method of determining the concen-tration of the analyte in the fluid test sample occurs in a disposable self-testing system.
36. The method of claim 30, wherein the method of determining the concen-tration of the analyte in the fluid test sample occurs in a clinical analyzer.
CA2457500A 2003-02-11 2004-02-05 Methods of determining the concentration of an analyte in a fluid test sample Expired - Fee Related CA2457500C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44622303P 2003-02-11 2003-02-11
US60/446,223 2003-02-11

Publications (2)

Publication Number Publication Date
CA2457500A1 true CA2457500A1 (en) 2004-08-11
CA2457500C CA2457500C (en) 2019-09-17

Family

ID=32682464

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2457500A Expired - Fee Related CA2457500C (en) 2003-02-11 2004-02-05 Methods of determining the concentration of an analyte in a fluid test sample

Country Status (10)

Country Link
US (1) US7132041B2 (en)
EP (2) EP1447452B1 (en)
JP (1) JP4740546B2 (en)
CN (2) CN101354391A (en)
AT (1) ATE419376T1 (en)
AU (1) AU2004200508A1 (en)
CA (1) CA2457500C (en)
DE (1) DE602004018695D1 (en)
DK (1) DK1447452T3 (en)
ES (1) ES2318207T3 (en)

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69809391T2 (en) 1997-02-06 2003-07-10 Therasense Inc SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
EP1404234B1 (en) 2001-06-12 2011-02-09 Pelikan Technologies Inc. Apparatus for improving success rate of blood yield from a fingerstick
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP1467206A1 (en) * 2003-04-08 2004-10-13 Roche Diagnostics GmbH Biosensor system
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282549B2 (en) 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
GB2404739B (en) * 2003-08-05 2006-04-12 E2V Tech Uk Ltd Sensor
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
AU2004288008B2 (en) * 2003-10-31 2008-04-17 Lifescan Scotland Limited A method of reducing interferences in an electrochemical sensor using two different applied potentials
US7655119B2 (en) * 2003-10-31 2010-02-02 Lifescan Scotland Limited Meter for use in an improved method of reducing interferences in an electrochemical sensor using two different applied potentials
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1713926B1 (en) 2004-02-06 2012-08-01 Bayer HealthCare, LLC Oxidizable species as an internal reference for biosensors and method of use
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
ES2567060T3 (en) * 2004-06-17 2016-04-19 Bayer Healthcare Llc Detection of incomplete filling of biosensors
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
JP4520873B2 (en) * 2005-02-02 2010-08-11 セイコーインスツル株式会社 Dissociation constant measurement apparatus, dissociation constant measurement method, and dissociation constant measurement program
PL1698891T3 (en) * 2005-03-03 2008-02-29 Apex Biotechnology Corp Method for reducing measuring bias in amperometric biosensors
CN101180403B (en) 2005-04-08 2014-11-12 拜尔保健有限公司 Oxidizable species as an internal reference in control solutions for biosensors
KR101321296B1 (en) * 2005-07-20 2013-10-28 바이엘 헬스케어 엘엘씨 Gated amperometry temperature determination
CA2616402A1 (en) * 2005-07-26 2007-02-01 Bayer Healthcare Llc Method and system for checking an electromechanical biosensor
WO2007019395A1 (en) * 2005-08-05 2007-02-15 Bayer Healthcare Llc Method for distinguishing electrochemical sensors
KR100801905B1 (en) * 2005-08-08 2008-02-12 주식회사 인포피아 Method and apparatus for measuring results of samples on biosensor
JP5671205B2 (en) 2005-09-30 2015-02-18 バイエル・ヘルスケア・エルエルシー Gated voltammetry
US7468125B2 (en) * 2005-10-17 2008-12-23 Lifescan, Inc. System and method of processing a current sample for calculating a glucose concentration
US8529751B2 (en) 2006-03-31 2013-09-10 Lifescan, Inc. Systems and methods for discriminating control solution from a physiological sample
US20070235346A1 (en) * 2006-04-11 2007-10-11 Popovich Natasha D System and methods for providing corrected analyte concentration measurements
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
ES2758478T3 (en) * 2006-05-03 2020-05-05 Ascensia Diabetes Care Holdings Ag Method for determining low fill level in an electrochemical biosensor and low fill level detection system
US7909983B2 (en) * 2006-05-04 2011-03-22 Nipro Diagnostics, Inc. System and methods for automatically recognizing a control solution
AU2007250086B2 (en) * 2006-05-08 2013-07-18 Bayer Healthcare Llc Electrochemical test sensor with reduced sample volume
US7993512B2 (en) 2006-07-11 2011-08-09 Bayer Healthcare, Llc Electrochemical test sensor
KR101096944B1 (en) * 2006-07-26 2011-12-20 파나소닉 주식회사 Biosensor measurement system and abnormal waveform detection method in biosensor
WO2008013224A1 (en) 2006-07-26 2008-01-31 Panasonic Corporation Biosensor measuring system, and measuring method
ES2825036T3 (en) 2006-10-24 2021-05-14 Ascensia Diabetes Care Holdings Ag Transient decay amperometry
US20080237142A1 (en) * 2007-04-02 2008-10-02 Battelle Energy Alliance, Llc Systems and methods for concentrating substances in fluid samples
MX2010003205A (en) * 2007-09-24 2010-04-09 Bayer Healthcare Llc Multi-electrode test sensors.
US8778168B2 (en) * 2007-09-28 2014-07-15 Lifescan, Inc. Systems and methods of discriminating control solution from a physiological sample
US8000918B2 (en) * 2007-10-23 2011-08-16 Edwards Lifesciences Corporation Monitoring and compensating for temperature-related error in an electrochemical sensor
CA2708038A1 (en) * 2007-12-10 2009-09-03 Bayer Healthcare Llc Slope-based compensation
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US8603768B2 (en) 2008-01-17 2013-12-10 Lifescan, Inc. System and method for measuring an analyte in a sample
AU2013202708B2 (en) * 2008-01-17 2014-08-21 Lifescan, Inc. System and method for measuring an analyte in a sample
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
DE502008001323D1 (en) * 2008-06-05 2010-10-28 Roche Diagnostics Gmbh A method for determining an analyte in a fluid sample and analyzer
US8551320B2 (en) 2008-06-09 2013-10-08 Lifescan, Inc. System and method for measuring an analyte in a sample
ES2700861T3 (en) * 2008-07-10 2019-02-19 Ascensia Diabetes Care Holdings Ag Systems and methods that include amperometric and voltammetric work cycles
BRPI0923342A2 (en) 2008-12-08 2016-01-12 Bayer Healthcare Llc biosensor system with signal adjustment
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
KR101058754B1 (en) 2009-09-22 2011-08-24 주식회사 인포피아 Biological Sample Quantitative Measurement Method and Biological Sample Quantitative Measurement System
JP5782044B2 (en) 2009-11-10 2015-09-24 バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC Underfill amount recognition system for biosensors
IL209760A (en) * 2009-12-11 2015-05-31 Lifescan Scotland Ltd Fill sufficiency method and system
US8101065B2 (en) * 2009-12-30 2012-01-24 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
US8877034B2 (en) 2009-12-30 2014-11-04 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
CN102121914B (en) * 2010-01-11 2013-09-11 明志科技大学 Electrochemical power supply method and device
MX2012010860A (en) * 2010-03-22 2013-03-05 Bayer Healthcare Llc Residual compensation for a biosensor.
CA2794978C (en) * 2010-03-31 2018-11-13 Michael Malecha Analyte measurement method and system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
KR101929058B1 (en) 2010-06-07 2018-12-13 바이엘 헬쓰케어 엘엘씨 Underfill management system for a biosensor
CA2798938C (en) 2010-06-07 2018-08-07 Bayer Healthcare Llc Slope-based compensation including secondary output signals
JP5812701B2 (en) * 2010-06-23 2015-11-17 アークレイ株式会社 Method for measuring plasma glucose
CN105181776B (en) * 2010-09-28 2018-09-18 生命扫描苏格兰有限公司 Analyte testing method and system with error capture
JP5819183B2 (en) 2011-02-03 2015-11-18 アークレイ株式会社 Analysis device, sensor inspection device, inspection method, and inspection program
EP2679992B1 (en) * 2011-02-23 2019-10-23 PHC Holdings Corporation Biological sample measuring system
JP5798618B2 (en) * 2011-03-28 2015-10-21 パナソニックヘルスケアホールディングス株式会社 Biological sample measuring device
US9316649B2 (en) 2011-05-10 2016-04-19 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device and method for measuring biological sample using same
US9775806B2 (en) 2011-09-21 2017-10-03 Ascensia Diabetes Care Holdings Ag Analysis compensation including segmented signals
US9823214B2 (en) * 2011-11-01 2017-11-21 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring apparatus
KR101367262B1 (en) * 2011-11-11 2014-02-26 주식회사 아이센스 Blood Glucose Sensor and sensing error detecting method using thereof
TWI513978B (en) * 2012-06-08 2015-12-21 Hmd Biomedical Inc Test strip, detecting device and detection method
US9005426B2 (en) * 2012-09-28 2015-04-14 Cilag Gmbh International System and method for determining hematocrit insensitive glucose concentration
CN103048219B (en) * 2012-12-05 2014-12-24 清华大学 Analytical method of iodine-containing hydriodic acid concentration
US9097659B2 (en) * 2013-03-14 2015-08-04 Bayer Healthcare Llc Maintaining electrode function during manufacture with a protective layer
EP2972260B1 (en) 2013-03-15 2018-07-11 Roche Diabetes Care GmbH Methods of scaling data used to construct biosensor algorithms
JP6282636B2 (en) 2013-04-26 2018-02-21 パナソニックヘルスケアホールディングス株式会社 Liquid sample measuring device, liquid sample measuring method, and biosensor
US9459232B2 (en) * 2013-09-05 2016-10-04 Lifescan Scotland Limited Method and system to determine erroneous measurement signals during a test measurement sequence
US9828621B2 (en) * 2013-09-10 2017-11-28 Lifescan Scotland Limited Anomalous signal error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte
CN105445341B (en) * 2014-09-12 2018-10-16 达尔生技股份有限公司 The detection method of the test strip exception of electrochemistry
CN106546642B (en) * 2015-09-23 2019-01-08 达尔生技股份有限公司 The detection method and detection device of electrochemical sensing test piece
DE102017211478B3 (en) * 2017-07-05 2018-09-20 Anvajo GmbH DEVICE AND METHOD FOR DETECTING A SPECIFIC ANALYTE IN A LIQUID SAMPLE AND USE OF THE DEVICE
CN111683595A (en) * 2017-11-01 2020-09-18 血糖监测技术公司 Method for adjusting a sensor
CN109946337B (en) * 2017-12-21 2022-01-04 王玉麟 Blood detection method
CN108132284B (en) * 2017-12-26 2019-11-29 三诺生物传感股份有限公司 A kind of test method of electrochemical sensor
CN113189189A (en) * 2021-04-01 2021-07-30 亚宝药业四川制药有限公司 Medicine detection method and quality control method of compound calcium gluconate oral solution
US20220404333A1 (en) * 2021-06-22 2022-12-22 C. R. Bard, Inc. In-Line Urinalysis System and Method
CN117030820B (en) * 2023-09-28 2024-01-09 艾康生物技术(杭州)有限公司 Measuring method of biosensor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0359831B2 (en) * 1988-03-31 2007-06-20 Matsushita Electric Industrial Co., Ltd. Biosensor and process for its production
US5320732A (en) * 1990-07-20 1994-06-14 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
US5264103A (en) * 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample
US5429735A (en) * 1994-06-27 1995-07-04 Miles Inc. Method of making and amperometric electrodes
DE4445947C2 (en) * 1994-12-22 1998-03-12 Draegerwerk Ag Process for the detection of sources of error in amperometric measuring cells
US5620890A (en) * 1995-03-14 1997-04-15 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to hygromycin B and the method of making the same
US5620579A (en) * 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
US5660791A (en) * 1996-06-06 1997-08-26 Bayer Corporation Fluid testing sensor for use in dispensing instrument
US5798031A (en) * 1997-05-12 1998-08-25 Bayer Corporation Electrochemical biosensor
WO1999060391A1 (en) * 1998-05-20 1999-11-25 Arkray, Inc. Method and apparatus for electrochemical measurement using statistical technique
US6278281B1 (en) * 1998-12-23 2001-08-21 Eaton Corporation Fluid condition monitor
US6193873B1 (en) * 1999-06-15 2001-02-27 Lifescan, Inc. Sample detection to initiate timing of an electrochemical assay
CA2305922C (en) 1999-08-02 2005-09-20 Bayer Corporation Improved electrochemical sensor design
US6841052B2 (en) * 1999-08-02 2005-01-11 Bayer Corporation Electrochemical-sensor design
US6477887B1 (en) 1999-08-30 2002-11-12 Masato Ozawa Gas sensor having pre-stressed terminal for contact with inserted sensor element
AU784254B2 (en) * 2001-05-21 2006-03-02 Bayer Corporation Improved electrochemical sensor

Also Published As

Publication number Publication date
DE602004018695D1 (en) 2009-02-12
JP2004245836A (en) 2004-09-02
US7132041B2 (en) 2006-11-07
ES2318207T3 (en) 2009-05-01
CN1558224B (en) 2013-08-21
ATE419376T1 (en) 2009-01-15
US20040154932A1 (en) 2004-08-12
CN1558224A (en) 2004-12-29
JP4740546B2 (en) 2011-08-03
AU2004200508A1 (en) 2004-08-26
DK1447452T3 (en) 2009-04-14
EP2017353A1 (en) 2009-01-21
CN101354391A (en) 2009-01-28
CA2457500C (en) 2019-09-17
EP1447452B1 (en) 2008-12-31
EP1447452A1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
CA2457500C (en) Methods of determining the concentration of an analyte in a fluid test sample
KR101360064B1 (en) Error detection in analyte measurements based on measurement of system resistance
EP1262769B1 (en) Improved electrochemical sensor
EP1074832B1 (en) Improved electrochemical-sensor design
AU2006233770B2 (en) Determination of partial fill in electrochemical strips
US8206564B2 (en) Biosensor calibration system
US20160274052A1 (en) Electrochemical Biosensor
KR20150036605A (en) System and method for detecting used and dried sensors
KR20120099452A (en) Underfill recognition system for a biosensor
JP4805259B2 (en) Detection of incomplete filling of biosensor
JP3991173B2 (en) Distinguishing liquid sample from control liquid
US20080169799A1 (en) Method for biosensor analysis
TWI274876B (en) Multistage examination method for a biosensor test piece
AU2011202737A1 (en) Determination of partial fill in electrochemical strips

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220207